ExodusPoint Capital Management’s bluebird bio BLUE Stock Holding History

ExodusPoint Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-64,833	Closed	-$674K	–	1547
2024 Q3	$674K	Buy	+64,833	New	+$1.08M	﹤0.01%	1093
2023 Q4	–	Sell	-21,187	Closed	-$1.29M	–	1502
2023 Q3	$1.29M	Buy	21,187 +7,606	+56%	+$534K	0.01%	859
2023 Q2	$894K	Buy	+13,581	New	+$994K	0.01%	1147
2023 Q1	–	Sell	-5,346	Closed	-$740K	–	1768
2022 Q4	$740K	Sell	5,346 -6,809	-56%	-$959K	0.01%	1049
2022 Q3	$1.54M	Buy	12,155 +3,517	+41%	+$398K	0.02%	921
2022 Q2	$715K	Buy	8,638 +5,193	+151%	+$403K	0.01%	1221
2022 Q1	$334K	Buy	+3,445	New	+$455K	﹤0.01%	1725
2021 Q4	–	Sell	-6,341	Closed	-$1.57M	–	2179
2021 Q3	$1.57M	Buy	+6,341	New	+$1.81M	0.02%	828
2020 Q4	–	Sell	-625	Closed	-$437K	–	1974
2020 Q3	$437K	Sell	625 -1,119	-64%	-$873K	0.01%	1088
2020 Q2	$1.38M	Buy	+1,744	New	+$1.32M	0.04%	582
2019 Q4	–	Sell	-340	Closed	-$404K	–	1537
2019 Q3	$404K	Buy	340 +55	+19%	+$84K	0.01%	749
2019 Q2	$469K	Buy	+285	New	+$493K	0.02%	497

Other funds holding BLUE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

ExodusPoint Capital Management's BLUE Position: Q4 2024 in Review

ExodusPoint Capital Management sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 64,833 shares — an estimated $674K sold.

ExodusPoint Capital Management first reported a position in BLUE in Q2 2019 and held it in 12 quarters. The position peaked at $1.57M in Q3 2021. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

ExodusPoint Capital Management reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 64,833 bluebird bio shares in Q4 2024, an estimated $674K.
ExodusPoint Capital Management first reported a position in bluebird bio in Q2 2019 and held it in 12 quarters.
ExodusPoint Capital Management's bluebird bio position peaked at $1.57M in Q3 2021.
83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.